別ウィンドウで開きます
English別ウィンドウで開きます Connect with MDV
Home > Service > MDV analyzer for Oncology
MDV analyzer for Oncology
MDV analyzer for Oncology background

Web Tool Service

MDV analyzer for Oncology

A specialized oncology data analysis tool.
MDV analyzer for Oncology

An oncology-specific analysis tool designed for the MDV medical data platform, renowned for its ability to provide comprehensive cancer-related information. This tool supports the strategic market positioning of your drug by analyzing the share of treatment regimens used in real-world clinical settings by treatment line. It helps estimate the number of potential patients prior to label expansion and assists in planning the launch of new oncology products.

    PC image PC image PC image
Oncology
Free Trial
Oncology
User Login
Contact us

EBM Medical Database

This tool leverages anonymized data collected from medical institutions including DPC and medical claims (receipt) data collected and processed into a large-scale database. It is widely used by pharmaceutical companies, medical device manufacturers, and other healthcare-related businesses for purposes such as marketing research and clinical studies.

construction of the Medical Database for MDV analyzer for Oncology

Feature Overview

MDV analyzer for Oncology allows fast and accurate analysis of complex treatment regimens. It helps oncology marketing teams conduct market research efficiently and provides robust support for R&D departments through detailed regimen pattern analysis.

Main Features of MDV analyzer for Oncology

  • Monthly Regimen Trend Analysis
  • Treatment Duration per Regimen
  • Regimen Pattern Analysis
  • Regimen Specific Dose per Administration

Regimen Identification Using Japan’s Largest Hospital Database

Capturing the actual conditions of diseases, drug usage, and clinical procedures at each point in the timeline allows for the early detection of potential risks.

Oncology Sample image1

Regimen Share by Line of Therapy

Analyze patient distribution across treatment regimens. Monitor shifts in treatment trends and assess real-world oncology practices with the latest data.

Oncology Sample image2

Analyzing regimen share by line of therapy—based on real-world clinical practice—enables strategic assessment of market positioning, evaluation of potential patient populations, and planning for label extensions or new product launches.

Oncology Sample image3

Analyzing treatment duration by regimen and line of therapy enables comparison of treatment lengths both across different lines for the same regimen and within the same line across different regimens.

Oncology Sample image4

Average dose per prescription for each drug within a regimen can be analyzed by treatment line, allowing for detailed assessment of prescribing trends.

Oncology Sample image5

Analyzing patient counts by regimen pattern for a given cancer type shows you where your product is used and how it fits into treatment sequences.

Oncology Sample image6

Additional cancer types not currently covered can be accommodated upon request.

Oncology
Free Trial
Oncology
User Login
Contact us

Main Steps to Get Started

Demo (feature overview)

Our representative will provide an introduction to the types of analyses that can be performed using each web tool.

下矢印

Consultation

The most suitable web tool will be proposed.

下矢印

Contract

Once the tool has been decided, we will provide a draft contract accordingly

下矢印

Delivery

We will set up the necessary accounts and share the login IDs and passwords prior to the start of service.

FAQs

Before use

Currently, the web tool is not available for trial purpose. Our representative can provide an introduction to the web tool based on your specific requirements. Please feel free to contact us.
Our representative can provide an introduction on how the web tool operates in advance. Please feel free to contact us.
We have brochures for our web tool services. Please contact us if you are interested.

About the specifications

Marketing: Prescription trends, market analysis, etc.
Academia and pharmacovigilance: Exploring potential research, regulatory submission, etc.
R&D: Field research, assessing status of drugs with similar effects to those under development, etc.
Maintenance is performed once a month, and the latest data becomes available after the maintenance.
It is possible. However, prior to publication, we require a third-party disclosure agreement（TPA) with our company and a review of the materials to be published.
We receive many disclosure requests every year, and the results are used not only for regulatory submissions but also during meetings with physicians.
The data analysis uses actual values, and some features have been implemented to allow for extrapolation, enabling you to view national-level data.
Within a single organization, there is no additional cost for using multiple accounts.
Yes, it is possible through a VPN connection or similar means.
Some of the web tools are available in English, please feel free to contact our representative for more information.

About the Hospital data

Currently, we have a coverage rate of approximately 30% of the 1,786 DPC-designated hospitals nationwide (as of December 31, 2024).
We collect insurance claim data for both inpatient and outpatient visits.
They are mainly advanced treatment hospitals, so they tend to have a higher number of patients with more severe conditions compared to clinics. However, there is also a significant number of patients in primary care areas, such as those with lifestyle-related diseases, and we receive many requests for analysis.
Our data covers DPC hospitals nationwide, and the age and gender distribution of patients is similar to the survey published by the Ministry of Health, Labour and Welfare regarding the patient distribution in medical institutions across Japan. Therefore, it is considered to be representative.
Since it is the largest database in Japan with over 50 million patients, the data has been utilized in research in different fields, including intractable and rare diseases.
Update is performed at the end of every month, and the data two months prior to the update will be the latest data. (For example, the data of January 2021 will be available after the update performed at the end of March 2021)
Given the large scale of the database, we are confident that we can secure a robust number of cases for research in any disease area.
The web tool does not currently include data fields for assessing disease severity. However, through a separate service, it is possible to obtain data fields that allow for the assessment of severity in certain disease areas.
There is a function in MDV analyzer that allows one to perform extrapolation to obtain results at the national level.
Each DPC hospital assigns a unique hospital-specific ID to each patient. Therefore, tracking is possible for both inpatient and outpatient data within the same DPC hospital. However, tracking after transfer to another hospital is not possible.
Unfortunately, our database only includes medical information that is eligible for insurance reimbursement, as it is based on claim data.
Oncology
Free Trial
Oncology
User Login
Contact us

page top

© Medical Data Vision Co., Ltd. All Rights Reserved.